Scoop Independent News
Peter Fergusson, CEO of Leukaemia & Blood Cancer New Zealand is heartened to hear that Pharmac has announced plans to back an Early Access Scheme which could potentially give cancer patients access to new and emerging medicines and treatments.
"Few cancer patients have time to wait, and many are prematurely dying because they do not always have access to the most optimal medication at the right time in their treatment cycle. Many of these emerging medicines and treatments are being fast-tracked, funded and made available in other OECD countries," says Fergusson.
Leukaemia & Blood Cancer New Zealand is part of a coalition of cancer NGOs called CANGO. A collaborative group of patient-focused cancer organisations that have proposed a Rapid Access Scheme to the government as part of the broader solution for improved cancer treatment in New Zealand. Read More